Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study
SK Bagherpour Doun, SE Alavi… - Tumor Biology, 2014 - Springer
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
[引用][C] Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study
SK Bagherpour Doun, SE Alavi… - Tumor …, 2014 - espace.library.uq.edu.au
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study
SKB Doun, SE Alavi, MKM Esfahani, HE Shahmabadi… - Tumor Biology, 2014 - infona.pl
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study
SKB Doun, SE Alavi, MKM Esfahani… - … biology: the journal …, 2014 - pubmed.ncbi.nlm.nih.gov
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study.
BD SK, SE Alavi, F Alavi, S Hamzei - Tumour Biology: the Journal …, 2014 - europepmc.org
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study
SKB Doun, SE Alavi, MKM Esfahani… - Tumor …, 2014 - search.proquest.com
One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …